One of the fastest growing pharma marketing companies in regulated markets, Accord boasts a wide range of product portfolio in Oncology, Biologicals, Immunosuppression, Cardio Vascular, Central Nervous System, Anti-diabetic, Nausea, Osteoporosis, and gastrointestinal track. With extensive network of branch offices and subsidiaries, Accord has established firm presence in almost all the markets.

Leveraging its advanced competency to enter into product alliances and strategic tie-ups with leading pharma giants, Accord is further consolidating its presence in US, Europe, Canada, Australia, New Zealand, South Africa, Brazil and Mexico besides Middle East and North African countries (MENA).

To view our presence across the Global Impression, please Click here...

Accord has to its credit of having garnered over 1100 live registrations in more than 55 countries across the globe with 15+ ANDAs in the pipeline.